The present invention provides selective 5-HT
7
receptor antagonist compounds of Formula I and their use in the treatment of migraine:
where A is —C(H)═ or —N═ and R
1-7
are as defined herein.
The present invention provides selective 5-HT7 receptor antagonist compounds of Formula I and their use in the treatment of migraine:
where A is —C(H)═ or —N═ and R1-7 are as defined herein.
[EN] 5-HT7 RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DU RÉCEPTEUR 5-HT7
申请人:LILLY CO ELI
公开号:WO2009048765A1
公开(公告)日:2009-04-16
The present invention provides selective 5-HT7 receptor antagonist compounds of Formula I and their use in the treatment of migraine: where A is C(H)= or -N= and R1-7 are as defined herein.